For the Inventor, By the Inventor

Enter assignee name

Banyu Pharmaceutical Co. Ltd

USPTO Granted Patents = 237

CIPO Patents = 5

EPO Patents = 5

Forward Citations = 1,257

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

344 inventors (with patents filed for the assignee):

Akio Kanatani (40 out of 46 patents)

Susumu Nakagawa (38 out of 38 patents)

Takehiro Fukami (32 out of 36 patents)

4. Ryosuke Ushijima (25 out of 25 patents)

5. Yoshikazu Iwasawa (23 out of 25 patents)

6. Norikazu Otake (23 out of 25 patents)

7. Hiroyuki Suda (22 out of 26 patents)

8. Kiyofumi Ishikawa (17 out of 17 patents)

9. Katsuhisa Kojiri (17 out of 17 patents)

10. Takashi Hayama (16 out of 16 patents)

11. Masaki Ihara (15 out of 20 patents)

12. Toshiaki Mase (15 out of 17 patents)

13. Koji Yamada (15 out of 15 patents)

14. Yuji Haga (13 out of 15 patents)

15. Akane Ishihara (13 out of 13 patents)

237 patents: Sort by Forward Citations

1. 7977336 - Aminopyrimidine derivatives as PLK1 inhibitors (2011-07-12),

2. 7960402 - Carbamoyl-substituted spiro derivative (2011-06-14),

3. 7960394 - Quinazoline derivative (2011-06-14),

4. 7915263 - Aminopyridine derivatives having aurora A selective inhibitory action (2011-03-29),

5. 7902376 - Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates (2011-03-08),

6. 7902369 - Diaryl-substituted five-membered heterocycle derivative (2011-03-08),

7. 7875633 - Phenylpyridone derivative (2011-01-25),

8. 7858800 - Biaryl derivatives (2010-12-28),

9. 7855294 - Cycloalkanopyridine derivative (2010-12-21),

10. 7834182 - Piperidine derivative (2010-11-16),

11. 7834019 - Substituted pyrazolo[3,4-d]pyrimidinone derivatives (2010-11-16),

12. 7834018 - Aminopyridine derivatives having aurora a selective inhibitory action (2010-11-16),

13. 7829586 - Aryl-substituted nitrogen-containing heterocyclic compounds (2010-11-09),

14. 7803807 - Benzimidazole derivatives (2010-09-28),

15. 7799820 - 2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions (2010-09-21),

Banyu Pharmaceutical Co. Ltd is a leading pharmaceutical company dedicated to improving global healthcare. With a focus on research, development, and manufacturing of innovative medicines, Banyu Pharma aims to contribute to the well-being of people worldwide. Our mission is to provide high-quality and accessible pharmaceutical products, including prescription drugs and over-the-counter medications. Committed to innovation and patient-centricity, we constantly strive to address unmet medical needs and improve treatment outcomes. Visit our website for more information and to explore our diverse product portfolio.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

237 Patents

#268 in Tokyo

#603 in Japan

#3,501 in the World

Banyu Pharmaceutical Co. Ltd

Forward Citations = 1,257

344 inventors:

Akio Kanatani (40 out of 46 patents)

Susumu Nakagawa (38 out of 38 patents)

Takehiro Fukami (32 out of 36 patents)

4. Ryosuke Ushijima (25 out of 25 patents)

5. Yoshikazu Iwasawa (23 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…